Ali Khan
Gastroenterology · Arlington, VANPI 1134514227
Payments from drug & device makers
Across 146 payments — averaging $24.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$720
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$439
- Boston Scientific$402
- Takeda Pharmaceuticals U.S.A., Inc.$249
- Johnson & Johnson$210
- QOL Medical, LLC$165
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,628100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 30 | $720 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 25 | $439 |
| Boston Scientific | 6 | $402 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $249 |
| Johnson & Johnson | 8 | $210 |
| QOL Medical, LLC | 5 | $165 |
| Si-bone, Inc. | 1 | $154 |
| Phathom Pharmaceuticals, Inc. | 10 | $151 |
| Ardelyx, Inc. | 6 | $144 |
| Pfizer | 7 | $144 |
| Bristol Myers Squibb | 6 | $130 |
| Regeneron Healthcare Solutions, Inc. | 5 | $114 |
| Sanofi | 3 | $88 |
| Novo Nordisk | 3 | $74 |
| Ipsen Biopharmaceuticals, Inc | 3 | $72 |
| Lilly USA, LLC | 2 | $55 |
| E.r. Squibb & Sons, L.L.C. | 2 | $48 |
| Alnylam Pharmaceuticals Inc. | 2 | $45 |
| Enterra Medical, Inc. | 2 | $43 |
| Vibrant Gastro, Inc. | 1 | $31 |
| Gilead | 1 | $27 |
| Echosens North America, Inc. | 1 | $24 |
| Ferring Pharmaceuticals Inc. | 1 | $24 |
| SK Life Science, Inc. | 1 | $24 |
| Digestive Care, Inc. | 1 | $21 |
| Capsovision, Inc. | 1 | $15 |
| Braintree Laboratories, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EXALT Model D$243
- Skyrizi$117
How this compares
$3,628 in reported general payments places this provider in the 45th percentile of 473 gastroenterology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 60 | $3,601 |
| Omeprazole | 81 | $1,003 |
| Pantoprazole Sodium | 56 | $638 |
| Famotidine | 21 | $264 |
| Esomeprazole Magnesium | 18 | $241 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 11 | $168 |
Paid to pharmacies, not to this prescriber.
Other gastroenterology in Arlington
- Larry ClarkLynchburg$8.5M
- Arun SanyalRichmond$5.5M
- Mitchell ShiffmanNewport News$4.7M
- Jasmohan BajajRichmond$4.4M
- Michael FuchsRichmond$1.9M
- Stephen CaldwellCharlottesville$1.8M
- Nirish ShahRoanoke$1.7M
- Michael RyanNorfolk$1.5M
- Omer KhalidNorth Chesterfield$1.2M
- Binu JohnRichmond$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.